Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

The federally funded facility is part of a broader effort to establish Southern New Hampshire as a biomanufacturing hub.

Sam Altman's like all of us — he's aging. But a company he's backed wants it to stop. So could you pony up some cash at a $5 billion valuation?

Also check out Christmas at Kohl Holiday Boutique on the Palo Alto Patch calendar ...

Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure cancer ...

Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies—therapies that cure cancer ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...